Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Free Cash Flow: 2011-2024

Historic Free Cash Flow for Adma Biologics (ADMA) over the last 11 years, with Dec 2024 value amounting to $110.4 million.

  • Adma Biologics' Free Cash Flow fell 104.48% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.7 million, marking a year-over-year decrease of 48.70%. This contributed to the annual value of $110.4 million for FY2024, which is 2641.28% up from last year.
  • Latest data reveals that Adma Biologics reported Free Cash Flow of $110.4 million as of FY2024, which was up 2,641.28% from $4.0 million recorded in FY2023.
  • Adma Biologics' 5-year Free Cash Flow high stood at $110.4 million for FY2024, and its period low was -$125.9 million during FY2021.
  • In the last 3 years, Adma Biologics' Free Cash Flow had a median value of $4.0 million in 2023 and averaged $13.7 million.
  • In the last 5 years, Adma Biologics' Free Cash Flow dropped by 9.72% in 2021 and then surged by 2,641.28% in 2024.
  • Over the past 5 years, Adma Biologics' Free Cash Flow (Yearly) stood at -$114.7 million in 2020, then dropped by 9.72% to -$125.9 million in 2021, then spiked by 41.68% to -$73.4 million in 2022, then surged by 105.49% to $4.0 million in 2023, then spiked by 2,641.28% to $110.4 million in 2024.